Source: Eur Respir J 2006; 27: 1076
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
D. DUSSER, M-L. BRAVO AND P. IACONO, ON BEHALF OF THE MISTRAL STUDY GROUP. EUR RESPIR J 2006; 27: 547-555.. THE EFFECT OF TIOTROPIUM ON EXACERBATIONS AND AIRFLOW IN PATIENTS WITH COPD.. Eur Respir J 2006; 27: 1076

Member's Comments

No comment yet.

Related content which might interest you: SYSTEMIC EFFECT OF CONTINUOUS TREATMENT WITH AZITHROMYCYN IN PATIENTS WITH SEVERE COPD AND FREQUENT EXACERBATIONS Source: International Congress 2019 – COPD clinical trials: new molecules and novel insights Year: 2019 BACTERIAL IMMUNOTHERAPY IN COPD AND/OR BRONCHIECTASIS FREQUENT EXACERBATOR PATIENTS. A RETROSPECTIVE STUDY. Source: International Congress 2018 – Integrated care and non-pharmacological management of COPD Year: 2018 NEUROMUSCULAR EFFICIENCY DURING EXERCISE IN COPD PATIENTS Source: International Congress 2019 – Exploring exercise responses in respiratory diseases Year: 2019 USEFULNESS OF MIRNAS AS PREDICTORS OF LUNG CANCER IN PATIENTS WITH COPD. A PILOT SUTDY Source: Virtual Congress 2021 – Mechanistic pathways in chronic and new lung diseases Year: 2021 IMMUNOLOGICAL EVENTS AND SURVIVAL IN LUNG CANCER PATIENTS WITH COPD Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer Year: 2020 PREVALENCE AND CHARACTERISTICS OF SAHS PATIENTS ADMITTED FOR COVID-19 PNEUMONIA Source: Virtual Congress 2021 – Sleep across the lifespan in the new era of COVID - 19 Year: 2021 A COMPARATIVE STUDY ON EFFECTS OF SUBSTANCE DEPENDENCE ON PULMONARY TUBERCULOSIS PATIENTS Source: Virtual Congress 2021 – Tuberculosis, COVID-19 and other comorbidities Year: 2021 PULMONARY REHABILITATION EFFECT ON SYSTEMIC INFLAMMATION VALUES, APOB48, LIPIDEMIA AND CARDIOVASCULAR RISK IN PATIENTS WITH COPD Source: International Congress 2019 – Pulmonary rehabilitation for obstructive lung diseases Year: 2019 EXTRARESPIRATORY SYMPTOM BURDEN IN PATIENTS HOSPITALIZED FOR A COPD EXACERBATION: IT’S NOT ONLY ABOUT RESPIRATORY SYMPTOMS Source: International Congress 2019 – Innovations in care for chronic respiratory conditions Year: 2019 MAINTAINING PULMONARY REHABILITATION EFFECTS IN COPD PATIENTS AT HOME – A PROTOCOL STUDY Source: Virtual Congress 2020 – Challenges and updates in nursing care around the world Year: 2020 OBSTACLE OF PHYSICAL ACTIVITY AND ACTIVITIES OF DAILY LIVING IN PATIENTS WITH COPD: DYSPNEA RELATED KINESIOPHOBIA Source: International Congress 2019 – Breathing, posture and physical activity in respiratory disease patients Year: 2019 THE LEVEL OF SOLUBLE CD8 MOLECULES IN SERUM AND SPUTUM IN COPD PATIENTS WITH AN EXACERBATION Source: International Congress 2017 – Highlights on clinical problems in COPD Year: 2017 LIPID PEROXIDATION IN PATIENTS WITH COPD AND CHRONIC HEART FAILURE. Source: International Congress 2018 – Functional genomics and COPD: new challenges Year: 2018 FACTORS INFLUENCING PHARMACOLOGICAL TREATMENT IN COPD PATIENTS  ENROLED IN AN INTEGRATED DISEASE MANAGEMENT PROGRAMME (IDMP) Source: International Congress 2018 – Integrating pharmacological and non-pharmacological management in COPD: are we there yet? Year: 2018 “CHAOS THEORY” IN HEART RATE VARIABILITY TO A FUNCTIONAL TEST IN PATIENTS WITH COPD Source: Virtual Congress 2020 – Prognosis and integrated management of COPD Year: 2020 PHYSIOLOGICAL EFFECTS OF THREE DIFFERENT VENTILATORY MODES IN PATIENTS WITH OBESITY HYPOVENTILATION SYNDROME UNDER NOCTURNAL NONINVASIVE VENTILATION: A PILOT RANDOMIZED STUDY Source: International Congress 2017 – Noninvasive ventilation for chronic respiratory failure Year: 2017 EVALUATION OF SYSTEMATIC INFLAMMATION, OXIDATIVE STRESS AND ENDOTHELIAL DISFUNCTION IN COPD, ASTHMATIC AND ACO PATIENTS WITH OBESITY. Source: Virtual Congress 2020 – Clinical and functional evaluation of asthmatics Year: 2020 INFLUENCE OF INDUCED IMMUNOSUPRESSION ON INFLAMMATION AND LUNGS REMODELING ON THE COPD MODEL Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair Year: 2019 SALBUTAMOL AND IPRATROPIUM BROMIDE ARE HIGH RISK FACTORS FOR ATRIAL ARRHYTHMIAS IN PATIENTS WITH COPD AND CVS DISEASES. Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies Year: 2019 EVALUATION OF OF SMALL AIRWAYS INFLAMMATORY PARAMETERS IN A GROUP OF ASTHMATIC PATIENTS Source: International Congress 2019 – Clinical approach to asthma management Year: 2019